Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,811 | -4,670 | N/A | N/A | N/A |
| Depreciation Amortization | 246 | 74 | N/A | N/A | N/A |
| Other Working Capital | 1,458 | 485 | N/A | N/A | N/A |
| Other Operating Activity | 3,969 | 438 | 0 | 0 | 0 |
| Operating Cash Flow | $-21,138 | $-3,673 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -456 | -175 | N/A | N/A | N/A |
| Investing Cash Flow | $-456 | $-175 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,043 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 39,728 | 59,445 | 0 | 0 | 0 |
| Financing Cash Flow | $131,771 | $59,445 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 57,972 | 2,375 | N/A | N/A | N/A |
| End Cash Position | 168,149 | 57,972 | N/A | N/A | N/A |
| Net Cash Flow | $110,177 | $55,597 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,138 | -3,673 | N/A | N/A | N/A |
| Capital Expenditure | -456 | -175 | N/A | N/A | N/A |
| Free Cash Flow | -21,594 | -3,848 | 0 | 0 | 0 |